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Background The increasing volume and variety of genotypic and phenotypic data is a
major defining characteristic of modern biomedical sciences. At the same time, the limita-
tions in technology for generating data and the inherently stochastic nature of biomolecular
events have led to the discrepancy between the volume of data and the amount of knowledge
3
gleaned from it. A major bottleneck in our ability to understand the molecular underpinnings
of life is the assignment of function to biological macromolecules, especially proteins. While
molecular experiments provide the most reliable annotation of proteins, their relatively low
throughput and restricted purview have led to an increasing role for computational func-
tion prediction. However, accurately assessing methods for protein function prediction and
tracking progress in the field remain challenging.
Methodology We have conducted the second Critical Assessment of Functional Annota-
tion (CAFA), a timed challenge to assess computational methods that automatically assign
protein function. One hundred twenty-six methods from 56 research groups were evaluated
for their ability to predict biological functions using the Gene Ontology and gene-disease as-
sociations using the Human Phenotype Ontology on a set of 3,681 proteins from 18 species.
CAFA2 featured significantly expanded analysis compared with CAFA1, with regards to
data set size, variety, and assessment metrics. To review progress in the field, the analysis
also compared the best methods participating in CAFA1 to those of CAFA2.
Conclusions The top performing methods in CAFA2 outperformed the best methods
from CAFA1, demonstrating that computational function prediction is improving. This
increased accuracy can be attributed to the combined effect of the growing number of ex-
perimental annotations and improved methods for function prediction. The assessment also
revealed that the definition of top performing algorithms is ontology specific, that different
performance metrics can be used to probe the nature of accurate predictions, and the relative
diversity of predictions in the biological process and human phenotype ontologies. While we
have observed methodological improvement between CAFA1 and CAFA2, the interpretation
of results and usefulness of individual methods remain context-dependent.
Introduction
Computational challenges in the life sciences have a successful history of driving the devel-
opment of new methods by independently assessing performance and providing discussion
forums for the researchers [14]. In 2010-2011, we organized the first Critical Assessment of
Functional Annotation (CAFA) challenge to evaluate methods for the automated annotation
of protein function and to assess the progress in method development in the first decade of
the 2000s [43]. The challenge used a time-delayed evaluation of predictions for a large set
of target proteins without any experimental functional annotation. A subset of these target
proteins accumulated experimental annotations after the predictions were submitted and was
used to estimate the performance accuracy. The estimated performance was subsequently
used to draw conclusions about the status of the field.
The CAFA1 experiment showed that advanced methods for the prediction of Gene On-
tology (GO) terms [5] significantly outperformed a straightforward application of function
transfer by local sequence similarity. In addition to validating investment in the development
of new methods, CAFA1 also showed that using machine learning to integrate multiple se-
quence hits and multiple data types tends to perform well. However, CAFA1 also identified
nontrivial challenges for experimentalists, biocurators and computational biologists. These
challenges include the choice of experimental techniques and proteins in functional studies
and curation, the structure and status of biomedical ontologies, the lack of comprehensive
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systems data that is necessary for accurate prediction of complex biological concepts, as
well as limitations of evaluation metrics [43, 19, 24, 47, 31]. Overall, by establishing the
state-of-the-art in the field and identifying challenges, CAFA1 set the stage for quantifying
progress in the field of protein function prediction over time.
In this study, we report on the major outcomes of the second CAFA experiment (CAFA2)
that was organized and conducted in 2013-2014, exactly three years after the original ex-
periment. We were motivated to evaluate the progress in method development for function
prediction as well as to expand the experiment to new ontologies. The CAFA2 experiment
also greatly expanded the performance analysis to new types of evaluation and included new
performance metrics.
Methods
Experiment overview
The timeline for the second CAFA experiment followed that of the first experiment and is
illustrated in Figure 1. Briefly, CAFA2 was announced in July 2013 and officially started
in September 2013, when 100,816 target sequences from 27 organisms were made available
to the community. Teams were required to submit prediction scores within the (0, 1] range
for each protein-term pair they chose to predict on. The submission deadline for depositing
these predictions was set for January 2014 (time point t0). We then waited until September
2014 (time point t1) for new experimental annotations to accumulate on the target proteins
and assessed the performance of the prediction methods. We will refer to the set of all
experimentally annotated proteins available at t0 as the training set and to a subset of target
proteins that accumulated experimental annotations during (t0, t1] and used for evaluation
as the benchmark set. It is important to note that the benchmark proteins and the resulting
analysis vary based on the selection of time point t1. For example, a preliminary analysis
of the CAFA2 experiment was provided during the Automated Function Prediction Special
Interest Group (AFP-SIG) meeting at the Intelligent Systems for Molecular Biology (ISMB)
conference in July 2014.
preparation
prediction
annotation growth assessment
Participants
Organizers
timeSep. 2013
Jan. 2014 Sep. 2014 Mar. 2015
Launch
CAFA2
(100,816 targets)
Close
submission
(126 models)
Release
results
Collect
benchmarks
(3,681 proteins)
t0 t1
Figure 1: Timeline for the CAFA2 experiment.
The participating methods were evaluated according to their ability to predict terms in
Gene Ontology (GO) [5] and Human Phenotype Ontology (HPO) [45]. In contrast with
CAFA1, where the evaluation was carried out only for the Molecular Function Ontology
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(MFO) and Biological Process Ontology (BPO), in CAFA2 we also assessed the perfor-
mance for the prediction of Cellular Component Ontology (CCO) terms in GO. The set of
human proteins was further used to evaluate methods according to their ability to associate
these proteins with disease terms from HPO, which included all sub-classes of the term
HP:0000118, “Phenotypic abnormality”.
In total, 56 groups submitting 126 methods participated in CAFA2. From those, 125
methods made valid predictions on a sufficient number of sequences. One-hundred and
twenty-one methods submitted predictions for at least one of the GO benchmarks, while 30
methods participated in the disease-gene prediction tasks using HPO.
Evaluation
The CAFA2 experiment expanded the assessment of computational function prediction com-
pared with CAFA1. This includes the increased number of targets, benchmarks, ontologies,
and method comparison metrics.
We distinguish between two major types of method evaluation. The first, protein-centric
evaluation, assesses performance accuracy of methods that predict all ontological terms as-
sociated with a given protein sequence. The second type, term-centric evaluation, assesses
performance accuracy of methods that predict if a single ontology term of interest is as-
sociated with a given protein sequence [43]. The protein-centric evaluation can be viewed
as a multi-label or structured-output learning problem of predicting a set of terms or a di-
rected acyclic graph (a subgraph of the ontology) for a given protein. Because the ontologies
contain many terms, the output space in this setting is extremely large and the evaluation
metrics must incorporate similarity functions between groups of mutually interdependent
terms (directed acyclic graphs). In contrast, the term-centric evaluation is an example of
binary classification, where a given ontology term is assigned (or not) to an input protein
sequence. These methods are particularly common in disease gene prioritization [39]. Put
otherwise, a protein-centric evaluation considers a ranking of ontology terms for a given
protein, whereas the term-centric evaluation considers a ranking of protein sequences for a
given ontology term.
Both types of evaluation have merits in assessing performance. This is partly due to the
statistical dependency between ontology terms, the statistical dependency among protein
sequences and also the incomplete and biased nature of the experimental annotation of
protein function [47]. In CAFA2, we provide both types of evaluation, but we emphasize
the protein-centric scenario for easier comparisons with CAFA1. We also draw important
conclusions regarding method assessment in these two scenarios.
No-knowledge and limited-knowledge benchmark sets
In CAFA1, a protein was eligible to be in the benchmark set if it had not had any experimentally-
verified annotations in any of the GO ontologies at time t0 but accumulated at least one
functional term with an experimental evidence code between t0 and t1. In CAFA2, we re-
fer to such benchmark proteins as no-knowledge benchmarks. On the other hand, proteins
with limited knowledge are those that had been experimentally annotated in one or two GO
ontologies, but not in all three, at time t0. For example, for the performance evaluation
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in MFO, a protein without any annotation in MFO prior to the submission deadline was
allowed to have experimental annotations in BPO and CCO.
During the growth phase, the no-knowledge targets that have acquired experimental
annotations in one or more ontologies became benchmarks in those ontologies. The limited-
knowledge targets that have acquired additional annotations became benchmarks only for
those ontologies for which there were no prior experimental annotations. The reason for using
limited-knowledge targets was to identify whether the correlations between experimental
annotations across ontologies can be exploited to improve function prediction.
The selection of benchmark proteins for evaluating HPO-term predictors was separated
from the GO analyses. There exists only a no-knowledge benchmark set in the HPO category.
Partial and full evaluation modes
Many function prediction methods apply only to certain types of proteins, such as proteins
for which 3D structure data are available, proteins from certain taxa, or specific subcellular
localizations. To accommodate these methods, CAFA2 provided predictors with an option
of choosing a subset of the targets to predict on as long as they computationally annotated
at least 5,000 targets, of which at least 10 accumulated experimental terms. We refer to
the assessment mode in which the predictions were evaluated only on those benchmarks for
which a model made at least one prediction at any threshold as partial evaluation mode. In
contrast, the full evaluation mode corresponds to the same type of assessment performed
in CAFA1 where all benchmark proteins were used for the evaluation and methods were
penalized for not making predictions.
In most cases, for each benchmark category, we have two types of benchmarks, no-
knowledge (NK) and limited-knowledge (LK), and two modes of evaluation, full-mode (FM)
and partial-mode (PM). Exceptions are all HPO categories that only have no-knowledge
benchmarks. The full mode is appropriate for comparisons of general-purpose methods
designed to make predictions on any protein, while the partial mode gives an idea of how
well each method performs on a self-selected subset of targets.
Evaluation metrics
Precision-recall (pr-rc) curves and remaining uncertainty-misinformation (ru-mi) curves
were used as the two chief metrics in the protein-centric mode. We also provide a single
measure evaluation in both types of curves as a real-valued scalar to compare methods; how-
ever, we note that any choice of a single point on those curves is somewhat arbitrary and
may not match the intended application objectives for a given algorithm. Thus, a careful
understanding of the evaluation metrics used in CAFA is necessary to properly interpret the
results.
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Precision (pr), recall (rc) and the resulting Fmax are defined as
pr(τ) = 1
m(τ)
m(τ)∑
i=1
∑
f 1 (f ∈ Pi(τ) ∧ f ∈ Ti)∑
f 1 (f ∈ Pi(τ))
,
rc(τ) = 1
ne
ne∑
i=1
∑
f 1 (f ∈ Pi(τ) ∧ f ∈ Ti)∑
f 1 (f ∈ Ti)
,
Fmax = max
τ
{
2 · pr(τ) · rc(τ)
pr(τ) + rc(τ)
}
,
where Pi(τ) denotes the set of terms that have predicted scores greater than or equal to τ
for a protein sequence i, Ti denotes the corresponding ground-truth set of terms for that
sequence, m(τ) is the number of sequences with at least one predicted score greater than or
equal to τ , 1 (·) is an indicator function and ne is the number of targets used in a particular
mode of evaluation. In the full evaluation mode ne = n, the number of benchmark proteins,
whereas in the partial evaluation mode ne = m(0), i.e. the number of proteins which were
chosen to be predicted using the particular method. For each method, we refer to m(0)/n as
the coverage because it provides the fraction of benchmark proteins on which the method
made any predictions.
The remaining uncertainty (ru), misinformation (mi) and the resulting minimum seman-
tic distance (Smin) are defined as
ru(τ) = 1
ne
ne∑
i=1
∑
f
ic(f) · 1 (f /∈ Pi(τ) ∧ f ∈ Ti) ,
mi(τ) = 1
ne
ne∑
i=1
∑
f
ic(f) · 1 (f ∈ Pi(τ) ∧ f /∈ Ti) ,
Smin = min
τ
{√
ru(τ)2 +mi(τ)2
}
,
where ic(f) is the information content of the ontology term f [12]. It is estimated in a
maximum likelihood manner as the negative binary logarithm of the conditional probability
that the term f is present in a protein’s annotation given that all its parent terms are also
present. Note that here, ne = n in the full evaluation mode and ne = m(0) in the partial
evaluation mode applies to both ru and mi.
In addition to the main metrics, we used two secondary metrics. Those were the weighted
version of the precision-recall curves and the version of the ru-mi curves normalized to
the [0, 1] interval. These metrics and the corresponding evaluation results are shown in
Supplementary Materials.
For the term-centric evaluation we used the area under the Receiver Operating Char-
acteristic (ROC) curve (AUC). The AUCs were calculated for all terms that have acquired
at least 10 positively annotated sequences, whereas the remaining benchmarks were used as
negatives. The term-centric evaluation was used both for ranking models and to differentiate
well and poorly predictable terms. The performance of each model on each term is provided
in Supplementary Materials.
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As we required all methods to keep two significant figures for prediction scores, the
threshold τ in all metrics used in this study exhaustively runs from 0.01 to 1.00 with the
step size of 0.01.
Data sets
Protein function annotations for the Gene Ontology assessment were extracted, as a union,
from three major protein databases that are available in the public domain: Swiss-Prot [6],
UniProt-GOA [30] and the data from the GO consortium web site [5]. We used evidence
codes EXP, IDA, IMP, IGI, IEP, TAS and IC to build benchmark and ground-truth sets.
Annotations for the HPO assessment were downloaded from the Human Phenotype Ontology
database [45].
MFO BPO CCO HPO
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Figure 2: CAFA2 benchmark breakdown. The left panel shows the benchmark size for each
of the four ontologies. The right panel lists the breakdown of benchmarks for both types over
11 species (with no less than 15 proteins) sorted according to the total number of benchmark
proteins. For both panels, dark colors (blue, red, yellow) correspond to no-knowledge (NK)
types, while their light color counterparts correspond to limited-knowledge (LK) types. The
size of CAFA 1 benchmarks are shown in gray.
Figure 2 summarizes the benchmarks we used in this study. The left panel shows the
benchmark sizes for each of the ontologies and compares these numbers to CAFA1. All
species that have at least 15 proteins in any of the benchmark categories are listed in the
right panel.
Baseline models
We built two baseline methods, Na¨ıve and BLAST, and compared them with all participating
methods. The Na¨ıve method simply predicts the frequency of a term being annotated in a
database [11]. BLAST was based on search results using the Basic Local Alignment Search
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Tool (BLAST) software against the training database [4]. A term will be predicted as the
highest local alignment sequence identity among all BLAST hits annotated with the term.
Both of these two methods were “trained” on the experimentally annotated proteins available
in Swiss-Prot at time t0, except for HPO where the two baseline models were trained using
the annotations from the t0 release of the Human Phenotype Ontology.
Results
Overall performance
The performance accuracies of the top 10 methods are shown in Figures 3 and 4. The
95% confidence intervals were estimated using bootstrapping on the benchmark set with
B = 10, 000 iterations [20]. The results provide a broad insight into the state of the art.
Predictors performed very differently across the four ontologies. Various reasons con-
tribute to this effect including: (1) the topological properties of the ontology such as the
size, depth, and branching factor; (2) term predictability; for example, the BPO terms are
considered to be more abstract in nature than the MFO and CCO terms; (3) the annotation
status, such as the size of the training set at t0 as well as various annotation biases [47].
In general, CAFA2 methods perform better in predicting MFO terms than any other
ontology. Top methods achieved the Fmax scores around 0.6 and considerably surpassed the
two baseline models. Maintaining the pattern from CAFA1, the performance accuracies in
the BPO category were not as good as in the MFO category. The best-performing method
scored slightly below 0.4.
For the two newly-added ontologies in CAFA2, we observed that the top predictors per-
formed no better than the Na¨ıve method under Fmax, whereas they slightly outperformed the
Na¨ıve method under Smin in CCO. One possible reason for the competitive performance of
the Na¨ıve method in the CCO category is the fact that a small number of relatively general
terms are frequently used, and those relative frequencies do not diffuse quickly enough with
the depth of the graph. For instance, the annotation frequency of “organelle” (GO:0043226,
level 2), “intracellular part” (GO:0044424, level 3) and “cytoplasm” (GO:0005737, level 4)
are all above the best threshold for the Na¨ıve method (τoptimal = 0.32). Correctly predict-
ing these terms increases the number of “true positives” and thus boosts the performance
of the Na¨ıve method under the Fmax evaluation. However, once the less informative terms
are down-weighted (using the Smin measure), the Na¨ıve method becomes significantly pe-
nalized and degraded. The weighted Fmax and normalized Smin evaluations can be found in
Supplementary Materials.
However, high frequency of general terms does not seem to be the major reason for the
observed performance in the HPO category. One possible explanation for this effect would
be that the average number of HPO terms associated with a human protein is much larger
than in GO. The mean number of annotations per protein in HPO is 84, while the MFO,
BPO and CCO the mean number of annotations per protein are 10, 39, and 14 respectively.
The high number of annotations per protein makes prediction using HPO terms significantly
more difficult. In addition, unlike for GO terms, the HPO annotations cannot be transferred
from other species based on homology and other available data. Successfully predicting the
10
Figure 3: Overall evaluation using the maximum F-measure, Fmax. Evaluation was carried
out on no-knowledge benchmark sequences in the full mode. The coverage of each method is
shown within its performance bar. A perfect predictor would be characterized with Fmax = 1.
Confidence intervals (95%) were determined using bootstrapping with 10,000 iterations on
the set of benchmark sequences. For cases in which a principal investigator participated in
multiple teams, only the results of the best-scoring method are presented. Details for all
methods are provided in Supplementary Materials.
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Figure 4: Overall evaluation using the minimum semantic distance, Smin. Evaluation was
carried out on no-knowledge benchmark sequences in the full mode. The coverage of each
method is shown within its performance bar. A perfect predictor would be characterized
with Smin = 0. Confidence intervals (95%) were determined using bootstrapping with 10,000
iterations on the set of benchmark sequences. For cases in which a principal investigator
participated in multiple teams, only the results of the best-scoring method are presented.
Details for all methods are provided in Supplementary Materials.
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HPO terms in the protein-centric mode is a difficult problem.
Term-centric evaluation
Protein-centric view, despite its power in showing the strengths of a predictor, does not
gauge a predictor’s performance for a specific function. We therefore also assessed predictors
in the term-centric manner by calculating AUCs for individual terms. Averaging those AUCs
over terms provides a metric for ranking predictors, whereas averaging performances over
terms provides insights into how well this term can be predicted computationally by the
community.
Figure 5 shows the performance evaluation where the AUCs for each method were aver-
aged over all terms for which at least ten positive sequences were available. Proteins without
predictions were counted as predictions with a score of 0. As shown in Figures 3-4, cor-
rectly predicting CCO and HPO terms for a protein might not be an easy task according to
the protein-centric results. However, the overall poor performances could also result from
the dominance of poorly predictable terms. Therefore, a term-centric view can help differ-
entiate prediction quality across terms. As shown in Figure 6, most of the terms in HPO
obtain AUC greater than the Na¨ıve model, with some terms on average achieving reasonably
well AUCs around 0.7. Depending on the training data available for participating methods,
well predicted phenotype terms range from mildly specific such as “Lymphadenopathy” and
“Thrombophlebitis” to general ones such as “Abnormality of the Skin Physiology”.
Performance on various categories of benchmarks
Easy vs. difficult benchmarks
As in CAFA1, the no-knowledge GO benchmarks were divided into “easy” versus “difficult”
categories based on their maximal global sequence identity with proteins in the training set.
Since the distribution of sequence identities roughly forms a bimodal shape (Supplementary
Materials), a cutoff of 60% was manually chosen to define the two categories. The same
cutoff was used in CAFA1. Unsurprisingly, across all three ontologies, the performance of
the BLAST model was substantially impacted for the difficult category because of the lack
of high sequence identity homologs and as a result, transferring annotations was relatively
unreliable. However, we also observed that most top methods were insensitive to the types
of benchmarks, which provides us with encouraging evidence that state-of-the-art protein
function predictors can successfully combine multiple potentially unreliable hits, as well as
multiple types of data, into a reliable prediction.
Species-specific categories
The benchmark proteins were split into even smaller categories for each species as long as the
resulting category contained at least 15 sequences. However, because of space limitations,
we only show the breakdown results on eukarya and prokarya benchmarks in Figure 7 (the
species-specific results are provided in Supplementary Materials). It is worth noting that the
performance accuracies on the entire benchmark sets were dominated by the targets from
eukarya due to their larger proportion in the benchmark set and annotation preferences. The
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Figure 5: Overall evaluation using the averaged AUC over terms with no less than 10 posi-
tive annotations. Evaluation was carried out on no-knowledge benchmark sequences in the
full mode. Error bars indicate the standard error in averaging AUC over terms for each
method. For cases in which a principal investigator participated in multiple teams, only the
results of the best-scoring method are presented. Details for all methods are provided in
Supplementary Materials.
eukarya benchmark rankings therefore coincide with the overall rankings, but the smaller
categories typically showed different rankings and may be informative to more specialized
research groups.
For all three GO ontologies, no-knowledge prokarya benchmark sequences collected over
the annotation growth phase mostly (over 80%) came from two species: E. coli and P. aerug-
inosa (for CCO, 21 out of 22 proteins were from E. coli). Thus, one should keep in mind
that the prokarya benchmarks essentially reflect the performance on proteins from these two
species. Methods predicting the MFO terms for prokaryotes are slightly worse than those for
eukaryotes. In addition, direct function transfer by homology for prokaryotes did not work
well using this ontology. However, the performance was better using the other two ontolo-
gies, especially CCO. It is not very surprising that top methods achieved good performance
for E. coli as it is a well-studied model organism.
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Figure 6: Averaged AUC per term for Human Phenotype ontology. Left panel: Terms are
sorted based on AUC, dashed red line indicates the performance of the Na¨ıve method. Right
panel: The top 10 accurately predicted terms without overlapping ancestors (except for the
root).
Top methods have improved since CAFA1
The second CAFA experiment was conducted three years after the first one. As our knowl-
edge of protein function has increased since then, it was worthwhile to assess whether com-
putational methods have also been improved and if so, to what extent. Therefore, to monitor
the progress of the community over time, we revisit some of the top methods in CAFA1 and
compare them with their successors.
The comparison was done on an overlapping benchmark set created from CAFA1 targets
and CAFA2 targets. More precisely, we used the stored predictions on the target proteins
from CAFA1 and compared them with the new predictions from CAFA2 on the overlapping
set of CAFA2 benchmarks and CAFA1 targets (a sequence had to be a no-knowledge target in
both experiments to be eligible in this evaluation). For this purpose, we used a hypothetical
ontology by taking the intersection of the two Gene Ontology snapshots (versions from
January 2011 and June 2013) so as to mitigate the influence of ontology changes. We thus
collected 356 benchmark proteins for MFO comparisons and 698 for BPO comparisons. The
two baseline methods were trained on respective Swiss-Prot annotations for both ontologies
so that they serve as controls for database change. In particular, SwissProt2011 (for CAFA1)
contained 29,330 and 31,282 proteins for MFO and BPO, while SwissProt2014 (for CAFA2)
contained 26,907 and 41,959 proteins for the two ontologies.
To conduct a “head-to-head” analysis between any two methods, we generated B =
10, 000 bootstrap samples and let methods compete on each such benchmark set. The average
performance metric as well as the number of wins were recorded. Figure 8 summarizes the
results of this analysis. We use a color code from green to red to indicate the performance
improvement δ from CAFA1 to CAFA2,
δ(m2,m1) =
1
n
n∑
i=1
F (i)max(m2)−
1
n
n∑
i=1
F (i)max(m1)
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Figure 7: Performance evaluation using the maximum F-measure, Fmax, on eukaryotic (left)
versus prokaryotic (right) benchmark sequences. Evaluation was carried out on no-knowledge
benchmark sequences in the full mode. The coverage of each method is shown within its per-
formance bar. Confidence intervals (95%) were determined using bootstrapping with 10,000
iterations on the set of benchmark sequences. For cases in which a principal investigator
participated in multiple teams, only the results of the best-scoring method are presented.
Details for all methods are provided in Supplementary Materials.
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where m1 and m2 stand for methods from CAFA1 and CAFA2, respectively, and F (i)max(·)
represents the Fmax of a method evaluated on the i-th bootstrapped benchmark set. The
selection of top methods for this study was based on their performance in each ontology
on the entire benchmark sets. Panels B and C in Figure 8 show the comparison between
baseline methods trained on different data sets. We see no improvements of these baselines
except for BLAST on BPO where it is slightly better to use the newer version of Swiss-Prot
as the reference database for the search. On the other hand, all top methods in CAFA2 out-
performed their counterparts in CAFA1. For predicting molecular functions, even though
transferring functions from BLAST hits does not give better results, the top models still
managed to perform better. It is possible that the newly acquired annotations since CAFA1
enhanced BLAST, which involves direct function transfer, and perhaps lead to better per-
formances of those “downstream” methods that rely on sequence alignments. However, this
effect does not completely explain the extent of performance improvement achieved by those
methods. This is promising evidence that top methods from the community have improved
since CAFA1 and that the improvement was not simply due to updates of curated databases.
Diversity of methodology
We analyzed the extent to which methods generated similar predictions within each ontology.
We calculated the pairwise Pearson correlation between methods on a common set of gene-
concept pairs and then visualized these similarities as networks (Supplementary Materials).
In the molecular function ontology, where we observed the highest overall performance
of prediction methods, eight of ten top methods were in the largest connected component.
In addition, we observed a high connectivity between methods, suggesting that the par-
ticipating methods are leveraging similar sources of data in similar ways. Predictions for
the biological process ontology showed a contrasting pattern. In this ontology, the largest
connected component contained only two of the top ten methods. The other top methods
were contained in components made up of other methods produced by the same lab. This
suggests that the approaches that participating groups have taken generate more diverse
predictions for this ontology and that there are many different paths to a top performing
biological process prediction method. Results for the human phenotype ontology were more
similar to the biological process ontology, while results for cellular component were more
similar in structure to molecular function.
Taken together, these results suggest that ensemble approaches that aim to include in-
dependent sources of high quality predictions may benefit from leveraging the data and
techniques used by different research groups and that such approaches that effectively weigh
and integrate disparate methods may demonstrate more substantial improvements over ex-
isting methods in the process and phenotype ontologies where current prediction approaches
share less similarity.
Conclusions
Accurately annotating the function of biological macromolecules is difficult, and requires
the concerted effort of experimental scientists, biocurators, and computational biologists.
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Molecular Function
Biological Process
Figure 8: CAFA1 versus CAFA2 (top methods). A comparison in Fmax between top 5 CAFA1
models against top 5 CAFA2 models. Colored boxes encode the results such that (1) colors
indicate margins of a CAFA2 method over a CAFA1 method in Fmax and (2) numbers in
the box indicate the percentage of wins. For both MFO and BPO results, A. CAFA1 top 5
models (rows, from top to bottom) against CAFA2 top 5 models (columns, from left to right)
B. Comparison of Na¨ıve baselines trained respectively on SwissProt2011 and SwissProt2014.
C. Comparison of BLAST baselines trained on SwissProt2011 and SwissProt2014.
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We conducted the second CAFA challenge to assess the status of computational function
prediction of proteins and to quantify the progress in the field. Following the success of
CAFA1 three years ago, we decided to significantly expand the number of protein targets, the
number of biomedical ontologies used for annotation, the number of analysis scenarios, as well
as the metrics used for evaluation. We believe the results of the CAFA2 experiment provide
useful information on the status of the state-of-the-art in protein function prediction, can
guide the development of new concept annotation methods, and help experimental studies
through prioritization. Understanding the function of biological macromolecules brings us
closer to understanding life at the molecular level and improving human health.
The field has moved forward
Three years ago, in CAFA1, we concluded that the top methods for function prediction
outperform straightforward function transfer by homology. In CAFA2, we observe that the
methods for function prediction have improved compared to those from CAFA1. As part of
the CAFA1 experiment, we stored all predictions from all methods on 48,298 target proteins
from 18 species. We used those stored predictions and compared them to the newly deposited
predictions from CAFA2 on the overlapping set of benchmark proteins and CAFA1 targets.
The head-to-head comparisons among top five CAFA1 methods against top five CAFA2
methods reveal that the top CAFA2 methods outperformed all top CAFA1 methods.
Although it is difficult to disentangle the contributions of larger training sets from those
of methodological novelties, the fact that the BLAST algorithm using the data from 2011
and data from 2014 showed little difference, led us to conclude that a larger share of the con-
tribution likely belongs to the new methods. The experiences from CAFA1 and continuous
AFP-SIG meetings every year during the ISMB conference where many new developments
are readily shared may have contributed to this outcome [53].
Evaluation metrics
A fair performance assessment in protein function prediction is far from straightforward.
Although various evaluation metrics have been proposed under the framework of multi-label
and structured-output learning, the evaluation in this subfield also needs to be interpretable
to a broad community of researchers as well as the public. To address this, we used several
metrics in this study as each provides useful insights and complements the others. Un-
derstanding the strengths and weaknesses of current metrics and developing better metrics
remains important.
One important observation with respect to metrics is that the protein-centric and term-
centric views may give different perspectives to the same problem. For example, while in
the MFO and BPO we generally observe positive correlation between the two, in CCO and
HPO these different metrics might lead to entirely different interpretations of the exper-
iment. Regardless of the underlying cause, as discussed in Results, it is clear that some
ontological terms are predictable with high accuracy and can be reliably used in practice
even in these ontologies. In the meantime, more effort will be needed to understand the
problems associated with statistical and computational aspects of method development.
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In CAFA2 we introduced minimum semantic distance as another protein-centric metric
[12]. The investigation of the BLAST baseline reveals that the best local sequence identity
cutoff for transferring experimental annotations from sequence hits occurs around 0.5 for
all three GO ontologies and just under (0.35) for HPO, if Fmax is used as the evaluation
metric. However, for Smin, these cutoffs are substantially higher to over 0.6 for MFO, 0.7 for
HPO and surprisingly over 0.9 for both BPO and CCO. We believe these higher thresholds
provide biologically interesting results and have thus decided to use both pr-rc curves and
ru-mi curves in protein-centric performance assessments.
Well-performing methods
We observe that participating methods usually specialize in one or a few categories of pro-
tein function prediction and have been developed with their own application objectives in
mind. Therefore, performance rankings of methods often change from one benchmark set to
another. There are complex factors that influence the final ranking including the selection of
the ontology, types of benchmark sets and evaluation, as well as evaluation metrics, as dis-
cussed earlier. Most of our assessment results show that the performances of top-performing
methods are generally comparable to each other. Thus, although a small group of methods
could be considered as generally good, there is no single method that dominates over all
benchmarks.
We also observed that when provided a chance to select a reliable set of predictions,
the methods generally perform better (partial evaluation mode vs. full evaluation mode).
Although most methods seem not to have been actively developed for the partial evaluation
mode, this outcome is very encouraging. On the other hand, the limited-knowledge category
of assessment seems to have not provided any boost in terms of performance accuracy.
However, this was a new prediction category in CAFA and so few methods may have been
optimized for prediction in the limited-knowledge scenario. Many important comparisons
can be found in Supplementary Materials.
Final notes
The automated functional annotation remains an exciting yet challenging task with impli-
cations relevant to the entirety of biomedical sciences. Three years after CAFA1, the top
methods from the community have shown encouraging progress in both MFO and BPO cat-
egories. However, in terms of raw scores, there is still significant room for improvement in
all ontologies, and particularly in BPO, CCO and HPO. There is also a need to develop an
experiment-driven, as opposed to curation driven, component of the evaluation to address
limitations for term-centric evaluation. In the future CAFA experiments, we will continue
to monitor the performance over time and invite a broad range of computational biologists,
computer scientists, statisticians and others to address these engaging problems of concept
annotation for biological macromolecules through CAFA.
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tion below provides additional CAFA2 analyses that are equivalent to those provided for
the CAFA1 experiment in the CAFA1 supplement; (2) the large data repository provides all
additional data, analyses as well as full prediction results for every method; (3) the entire
library of code used in CAFA2 is available at https://github.com/yuxjiang/CAFA2.
Supplementary Information
The section below contains supplementary figures, analyses, as well as information related
to participating methods.
Additional data
The following contains additional data analyses and raw data: https://dx.doi.org/10.
6084/m9.figshare.2059944
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Supplementary Information
“An expanded evaluation of protein function prediction methods
shows an improvement in accuracy”
Content:
• Supplementary Figures.
1. Benchmark annotation depth distribution.
2. Top predictors, precision-recall curves.
3. Benchmark sequence identity histogram.
4. Top predictors, easy vs. difficult, precision-recall curves.
5. Top predictors, eukarya vs. prokarya, precision-recall curves.
6. Top predictors, species breakdown, Fmax bars.
7. Top predictors, weighted precision-recall curves.
8. Top predictors, normalized remaining uncertainty-misinformation.
9. Similarity networks between methods.
• Supplementary Table 1. Participating teams.
• Supplementary Table 2. Keywords.
Additional supplementary data (297MB) provides all additional data, analyses and full pre-
diction results for every method. It is available at:
https://dx.doi.org/10.6084/m9.figshare.2059944
Code used in CAFA2 is available at:
https://github.com/yuxjiang/CAFA2
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Supplementary Figure 1 Distribution of depths of the leaf annotations, over all bench-
marks in (A) Molecular Function ontology, (B) Biological Process ontology, (C) Cellular
Component ontology and (D) Human Phenotype ontology. A leaf term for a benchmark
protein is defined as any term whose descendant nodes (more specific nodes) are not among
the experimentally determined terms for that protein.
(A) (B)
(C) (D)
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Supplementary Figure 2 Precision-recall curves for the top-performing methods for (A)
Molecular Function ontology, (B) Biological Process ontology, (C) Cellular Component ontol-
ogy and (D) Human Phenotype ontology. All panels show the top ten participating methods
in each category, as well as the Na¨ıve and BLAST baseline methods. Points corresponding
to the maximum F-measure are marked in circles on each curve. The legend provides the
maximum F-measure (F ) and coverage (C) for all methods. In cases where a Principal In-
vestigator (PI) participated with multiple teams, only the results of the best scoring method
are presented.
Supplementary Figure 2A:
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Supplementary Figure 2B:
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Supplementary Figure 2C:
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Supplementary Figure 2D:
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Supplementary Figure 3 The histogram of pairwise sequence identities between each
benchmark proteins and the experimentally annotated template most similar to it: (A)
Molecular Function ontology, (B) Biological Process ontology, and (C) Cellular Component
ontology. The histograms roughly determine two groups of benchmarks: easy – with maxi-
mum global sequence identity greater than or equal to 60%, and difficult – with maximum
global sequence identity below 60%.
(A) (B)
(C)
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Supplementary Figure 4 Precision-recall curves for the top-performing methods for (A)
easy benchmark category and Molecular Function ontology, (B) difficult benchmark cate-
gory and Molecular Function ontology, (C) easy benchmark category and Biological Process
ontology, (D) difficult benchmark category and Biological Process ontology, (E) easy bench-
mark category and Cellular Component ontology and (F) difficult benchmark category and
Cellular Component ontology. All panels show the top ten participating methods in each
category, as well as the Na¨ıve and BLAST baseline methods. Points corresponding to the
maximum F-measure are marked in circles on each curve. The legend provides the maximum
F-measure (F ) and coverage (C) for all methods. In cases where a Principal Investigator (PI)
participated with multiple teams, only the results of the best scoring method are presented.
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Supplementary Figure 4A (easy):
Supplementary Figure 4B (difficult):
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Supplementary Figure 4C (easy):
Supplementary Figure 4D (difficult):
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Supplementary Figure 4E (easy):
Supplementary Figure 4F (difficult):
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Supplementary Figure 5 Precision-recall curves for the top-performing methods for (A) eu-
karyotic benchmark category and Molecular Function ontology, (B) prokaryotic benchmark
category and Molecular Function ontology, (C) eukaryotic benchmark category and Biolog-
ical Process ontology, (D) prokaryotic benchmark category and Biological Process ontology,
(E) eukaryotic benchmark category and Cellular Component ontology and (F) prokaryotic
benchmark category and Cellular Component ontology. All panels show the top ten partici-
pating methods in each category, as well as the Na¨ıve and BLAST baseline methods. Points
corresponding to the maximum F-measure are marked in circles on each curve. The legend
provides the maximum F-measure (F ) and coverage (C) for all methods. In cases where
a Principal Investigator (PI) participated with multiple teams, only the results of the best
scoring method are presented.
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Supplementary Figure 5A (eukarya):
Supplementary Figure 5B (prokarya):
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Supplementary Figure 5C (eukarya):
Supplementary Figure 5D (prokarya):
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Supplementary Figure 5E (eukarya):
Supplementary Figure 5F (prokarya):
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Supplementary Figure 6 Performance evaluation based on the maximum F-measure for
the top-performing methods for the Molecular Function ontology (A–F), Biological Process
ontology (G–O), and Cellular Component ontology (P–V). Only the species with 15 bench-
mark proteins or more are included. All bars show the top ten participating methods as
well as the Na¨ıve and BLAST baseline methods. A perfect predictor would be characterized
with Fmax of 1. Confidence interval (95%) were determined using bootstrapping with 10,000
iterations on the set of target sequences.
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Supplementary Figure 6A (Arabidopsis thaliana):
Supplementary Figure 6B (Escherichia coli K12):
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Supplementary Figure 6C (Homo sapiens):
Supplementary Figure 6D (Mus musculus):
40
Supplementary Figure 6E (Pseudomonas aeruginosa):
Supplementary Figure 6F (Rattus norvegicus):
41
Supplementary Figure 6G (Arabidopsis thaliana):
Supplementary Figure 6H (Danio rerio):
42
Supplementary Figure 6I (Dictyostelium discoideum):
Supplementary Figure 6J (Drosophila melanogaster):
43
Supplementary Figure 6K (Escherichia coli K12):
Supplementary Figure 6L (Homo sapiens):
44
Supplementary Figure 6M (Mus musculus):
Supplementary Figure 6N (Pseudomonas aeruginosa):
45
Supplementary Figure 6O (Rattus norvegicus):
46
Supplementary Figure 6P (Arabidopsis thaliana):
Supplementary Figure 6Q (Drosophila melanogaster):
47
Supplementary Figure 6R (Escherichia coli K12):
Supplementary Figure 6S (Homo sapiens):
48
Supplementary Figure 6T (Mus musculus):
Supplementary Figure 6U (Rattus norvegicus):
49
Supplementary Figure 6V (Saccharomyces cerevisiae):
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Supplementary Figure 7 Weighted precision-recall curves for the top-performing methods
for (A) Molecular Function ontology, (B) Biological Process ontology, (C) Cellular Compo-
nent ontology and (D) Human Phenotype ontology. All panels show the top ten participating
methods in each category, as well as the Na¨ıve and BLAST baseline methods. Points cor-
responding to the maximum weighted F-measure are marked in circles on each curve. The
legend provides the maximum weighted F-measure (F ) and coverage (C) for all methods. In
cases where a Principal Investigator (PI) participated with multiple teams, only the results
of the best scoring method are presented.
Calculation of the weighted precision-recall curve. Each term f in the ontology was
weighted according to the information content of that term. The information content of the
term f was calculated as
ic(f) = log2
1
Pr (f |P(f)) ,
where Pr (f |P(f)) is the probability that the term f in the ontology is associated to a
protein given that all of its parents are associated. (probabilities were determined based on
the union of Swiss-Prot, UniProt-GOA and GO Consortium databases). Weighted precisions
and recalls are calculated as
wpr(τ) = 1
m(τ)
m(τ)∑
i=1
∑
f ic(f) · 1 (f ∈ Pi(τ) ∧ Ti(τ))∑
f ic(f) · 1 (f ∈ Pi(τ))
, and
wrc(τ) = 1
ne
ne∑
i=1
∑
f ic(f) · 1 (f ∈ Pi(τ) ∧ Ti(τ))∑
f ic(f) · 1 (f ∈ Ti(τ))
,
where Pi(τ) is the set of predicted terms for protein i with score no less than threshold τ
and Ti is the set of true terms for protein i, m(τ) is the number of sequences with at least
one predicted score greater than or equal to τ , and ne is the number of proteins used in a
particular mode of evaluation. In the full evaluation mode ne = n, the number of benchmark
proteins, whereas in the partial evaluation mode ne = m(0).
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Supplementary Figure 7A:
Supplementary Figure 7B:
52
Supplementary Figure 7C:
Supplementary Figure 7D:
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Supplementary Figure 8 Normalized remaining uncertainty-misinformation curves for the
top-performing methods for (A) Molecular Function ontology, (B) Biological Process ontol-
ogy, (C) Cellular Component ontology and (D) Human Phenotype ontology. All panels show
the top ten participating methods in each category, as well as the Na¨ıve and BLAST baseline
methods. Points corresponding to the minimum normalized semantic distance are marked in
circles on each curve. The legend provides the minimum normalized semantic distance (S)
and coverage (C) for all methods. In cases where a Principal Investigator (PI) participated
with multiple teams, only the results of the best scoring method are presented.
Calculation of the normalized remaining uncertainty-misinformation curve.
nru(τ) = 1
ne
ne∑
i=1
∑
f ic(f) · 1 (f /∈ Pi(τ) ∧ f ∈ Ti)∑
f ic(f) · 1 (f ∈ Pi(τ) ∨ f ∈ Ti)
, and
nmi(τ) = 1
ne
ne∑
i=1
∑
f ic(f) · 1 (f ∈ Pi(τ) ∧ f /∈ Ti)∑
f ic(f) · 1 (f ∈ Pi(τ) ∨ f ∈ Ti)
,
where Pi(τ) is the set of predicted terms for protein i with score no less than threshold τ and
Ti is the set of true terms for protein i, and ne is the number of proteins used in a particular
mode of evaluation. In the full evaluation mode ne = n, the number of benchmark proteins,
whereas in the partial evaluation mode ne is the number of proteins that have at least one
positive predicted score.
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Supplementary Figure 8A:
Supplementary Figure 8B:
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Supplementary Figure 8C:
Supplementary Figure 8D:
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Supplementary Figure 9 Similarity network of participated methods for (A) Molecular
Function ontology, (B) Biological Process ontology, (C) Cellular Component ontology and
(D) Human Phenotype ontology. For all panels, similarities are computed as the Pearson’s
correlation coefficient between methods with a 0.75 cutoff for illustration purposes. A unique
color is assigned to all methods submitted under the same principal investigator. Not eval-
uated (organizer’s) methods are shown in triangles, while benchmark methods (Na¨ıve and
BLAST) are shown in squares. Top 10 methods are highlighted with enlarged nodes and
circled in red. Edge width indicates the strength of similarity. Nodes are labelled with the
name of methods followed by “team-model” if multiple teams/models are submitted.
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Supplementary Figure 9A:
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Supplementary Figure 9B:
59
Supplementary Figure 9C:
60
Supplementary Figure 9D:
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Supplementary Table 1: Participating methods grouped by Prin-
cipal Investigators
Principal Investigator Method Name Model (keywords) Citation
Asa Ben-Hur GOstruct Model 1 (sa,sp,pp,pi,ge,gi,lt,gc,ml,nlp) [49]
Richard Bonneau PULP Model 1 (ph,sp,pp,pi,ge,ps,pps,dp,ml,or) [56, 55, 54]
Model 2 (ph,sp,pp,pi,ge,ps,pps,dp,ml)
Steven Brenner SIFTER 2.4 * Model 1 (ph,ml,or,pa,ho) [46, 21]
Model 2 (ph,ml,or,pa,ho)
Model 3 (ph,ml,or,pa,ho)
Rita Casadio BAR++ Model 1 (sa,spa,pp,pps,ml,ho,hmm) [7, 42]
Model 2 (sa,spa,pp,pps,ml,ho,hmm)
Jianlin Cheng ProFun Model 1 (spa,sp,gi,gc,dp,gd) [9]
Model 2 (spa,dp)
Model 3 (spa,gi,gc,dp,gd)
ProFun/donet Model 1 (ppa,spa) [51]
Model 2 (ppa,spa)
Model 3 (ppa,spa)
Wyatt Clark Yale Model 1 (pi)
Model 2 (pi)
Model 3 (pi)
Christophe Dessimoz GORBI Model 1 (ml,or,pa,ho,gc) [48]
Model 2 (ml,or,pa,ho,gc)
Model 3 (or,pa,ho,sa,spa,ppa,ph,hmm)
CBRG Model 1 (or,pa,ho) [3]
Model 2 (or,pa,ho)
Model 3 (or)
Tunca Dogan PANdeMIC Model 1 (sa,ml,ho)
Filip Ginter EVEX Model 1 (sa,ml,sp) [50]
Model 2 (sa,ml,sp)
Julian Gough Gough Lab/GoughGroup Model 1 (sa,spa,hmm)
Model 2 (pps,hmm)
Model 3 (pi)
Gough Lab/D2P2 Model 1 (pp,sa,spa,hmm) [40]
Model 2 (pp,pi)
Model 3 (pp)
Gough Lab/dcGO Model 1 (pps,pp,sa,spa,hmm,pi) [23]
Model 2 (pps,pp,sa,spa,hmm,pi)
Model 3 (pps,pp,sa,spa,hmm,pi)
Gough Lab/SUPERFAMILY Model 1 (pps,pp,sa,spa,hmm,pi) [18]
Model 2 (pi)
Model 3 (pp,sa,spa,hmm)
Gough Lab/dcGOpredictor Model 1 (pps,sa,spa,hmm,pi)
Model 2 (pps,sa,spa,hmm,pi)
Liisa Holm SANS Model 1 (sa) [33]
Model 2 (sa)
Model 3 (sa)
PANNZER Model 1 (sa,ph,or,pa,ho,nlp,ofi) [34]
Model 2 (sa,ph,or,pa,ho,nlp,ofi)
Model 3 (sa,ph,or,pa,ho,nlp,ofi)
Wen-Lian Hsu IASL Model 1 (sa,spa,sp)
Model 2 (sa,spa,sp)
Model 3 (sa,spa,sp)
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Principal Investigator Method Name Model (keywords) Citation
David Jones Jones-UCL/jfpred-RF Model 1 (hmm,ppa,sp,pi,or,lt,ml) [15]
Jones-UCL/jfpred-FP Model 1 (hmm,ppa,sp,pi,or,lt,ml)
Model 2 (sp,pp,pps,ml)
Model 3 (sp,pp,pps,ml)
Jones-UCL/jfpred-PB Model 1 (hmm,ppa,sp,pi,or,lt,ml)
Model 2 (sa,spa)
Model 3 (hmm,ppa)
Daisuke Kihara ESG Model 1 (sa) [10]
Model 2 (sa)
CONS Model 1 (sa) [32]
FPM Model 1 (sa)
Model 2 (sa)
PFPDB Model 1 (sa)
Model 2 (sa)
ESGDB Model 1 (sa)
Model 2 (sa)
PFP Model 1 (sa) [29, 28]
Model 2 (sa)
Sean Mooney g2p buck (not evaluated) Model 1 (N/A)
Michal Linial Go2Proto Model 1 (sa,sp,php,pp,cm,ml,or,pa,ho,ofi)
Model 2 (sa,sp,php,pp,cm,ml,or,pa,ho,ofi)
Model 3 (sa,sp,php,pp,cm,ml,or,pa,ho,ofi)
Yves Moreau ENDEAVOUR Model 1 (sa,ph,pi,ge,lt,ml,ofi) [1]
Model 2 (sa,ph,pi,ge,lt,ml,ofi)
Model 3 (sa,ph,pi,ge,lt,ml,ofi)
KernelFusion Model 1 (sa,pi,ge,lt,ml,ofi) [57, 17]
Model 2 (sa,pi,ge,lt,ml,ofi)
Model 3 (sa,pi,ge,lt,ml,ofi)
Christine Orengo Orengo-FunFams/MDA Model 1 (ml) [16]
Model 2 (sp)
Model 3 (pi)
Orengo-FunFams Model 1 (spa,ppa,ho,hmm)
Model 2 (spa,ppa,ho,hmm)
Model 3 (spa,ppa,ho,hmm)
Alberto Paccanaro Paccanaro Lab Model 1 (sa,spa,pi,ge,lt,gc,ml,or.ho)
Model 2 (spa,hmm,ml)
Paul Pavlidis Moirai Model 1 (ofi)
Model 2 (ofi)
Model 3 (ofi)
Predrag Radivojac FANN-GO (not evaluated) Model 1 (sa,ml) [11]
Model 2 (sa,ml)
Model 3 (sa,ml)
Burkhard Rost Rost Lab Model 1 (sa,spa,ppa,sp,dp,ml) [25]
Model 2 (sa,spa,ppa,sp,dp,ml)
Model 3 (sa,spa,ppa,sp,dp,ml)
Rost Lab/metastudent2 Model 1 (sa,ml,or,pa,ho) [27]
Asaf Salamov COPBP Model 1 (N/A)
Fran Supek PhyloScriptors Model 1 (ph,gc,ml,pa,or)
Weidong Tian Tian Lab Model 1 (sa) [26]
Model 2 (sa)
Stefano Toppo Argot2 Model 1 (sa,spa) [22]
Toppo/van Dijk † argot2bmrf Model 1 (sp,pi,ge,gi,ml,sa,spa)
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Principal Investigator Method Name Model (keywords) Citation
Model 2 (sp,pi,ge,gi,ml,sa,spa)
Silvio Tosatto INGA-Tosatto Model 1 (hmm,ppa,sa,pi) [41]
Michael Tress SIAM Model 1 (sa,ho,sp,ps,php,spa,ppa,sta,cm) [38]
Model 2 (ps,php,spa,ppa,sta,cm)
Model 3 (sa,ho,sp)
Hafeez Ur Rehman PFPPipeLine Model 1 (sa,pi,ml,ho,ofi) [8]
Giorgio Valentini Anacleto Lab Model 1 (ml,sa) [44]
Model 2 (ml,sa)
Model 3 (ml,sa)
Aalt-Jan van Dijk BMRF Model 1 (sp,pi,ge,gi,ml) [35, 36]
Model 2 (sp,pi,ge,gi,ml)
Nevena Veljkovic ISM AP Model 1 (ppa,php)
Model 2 (ppa,php,ge)
Model 3 (ppa,php,ge)
Ricardo Vencio SIFTER-T Model 1 (spa,ml,ho) s [2]
Jo¨rg Vogel APRICOT Model 1 (ho,hmm,ppa,pp)
Model 2 (ho,hmm,ppa,pp)
Slobodan Vucetic MS-kNN Model 1 (ml,sa,ge) [37]
Model 2 (ml,sa,ge)
Model 3 (ml,sa,ge)
Zheng Wang PANDA Model 1 (spa,ppa,ph,or,pa,ho)
Model 2 (spa,ppa,ph,or,pa,ho)
Model 3 (spa,ppa,ph,or,pa,ho)
Mark Wass CombFunc Model 1 (spa,sa,ml,ge,pi) [52]
N/A ‡ Blast2GO Model 1 (sa) [13]
* SIFTER is expected to work well on microbial proteins
†This is a joint group of Stefano Toppo and Aalt-Jan van Dijk
‡Blast2GO predictions were downloaded from the website https://www.blast2go.com one week before the
prediction deadline and converted into appropriate submission format by the CAFA organizers
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Supplementary Table 2: Keywords
Code Keyword Code Keyword
sa sequence alignment sta structure alignment
spa sequence-profile alignment cm comparative model
ppa profile-profile alignment pps predicted protein structure
ph phylogeny dp de novo prediction
sp sequence properties ml machine learning
php physicochemical properties gne genome environment
pp predicted properties op operon
pi protein interactions or ortholog
ge gene expression pa paralog
ms mass spectrometry ho homolog
gi genetic interactions hmm hidden Markov model
ps protein structure cd clinical data
lt literature gd genetic data
gc genomic context nlp natural language processing
sy synteny ofi other functional information
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